Tag: <span>Mesothelioma News</span>

Concordia Healthcare Corp. Announces Acquisition Of Pinnacle Biologics, Inc.

TORONTO, ON AND BANNOCKBURN, IL, Dec. 24, 2013 /PRNewswire/ – Concordia Healthcare Corp. , an integrated, specialty healthcare company focused on the acquisition of legacy pharmaceutical products and medical devices and the acquisition and/or developme…

Concordia Healthcare Corp. Announces Acquisition Of Pinnacle Biologics, Inc.

TORONTO, ON AND BANNOCKBURN, IL, Dec. 24, 2013 /PRNewswire/ – Concordia Healthcare Corp. , an integrated, specialty healthcare company focused on the acquisition of legacy pharmaceutical products and medical devices and the acquisition and/or developme…

New data for engineering immune cells shows early promise in solid tumors

Engineered immune cells, called CARTmeso cells, designed to direct antitumor immune responses toward tumors that carry a protein called mesothelin, showed antitumor activity in two patients with advanced cancers that had not responded to prior treatmen…

New data for engineering immune cells shows early promise in solid tumors

Engineered immune cells, called CARTmeso cells, designed to direct antitumor immune responses toward tumors that carry a protein called mesothelin, showed antitumor activity in two patients with…

Breath of Life Foundation Awards $60,000 Research Grant to Providence Hospital

Providence Hospital Receives a $60,000 Grant for Asbestos Research

New data for engineering immune cells shows early promise in solid tumors

Engineered immune cells, called CARTmeso cells, designed to direct antitumor immune responses toward tumors that carry a protein called mesothelin, showed antitumor activity in two patients with advanced cancers that had not responded to prior treatmen…

New data for engineering immune cells shows early promise in solid tumors

Engineered immune cells, called CARTmeso cells, designed to direct antitumor immune responses toward tumors that carry a protein called mesothelin, showed antitumor activity in two patients with advanced cancers that had not responded to prior treatmen…